RecruitingPhase 1NCT07158853

Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

Sponsor

University of Minnesota

Enrollment

40 participants

Start Date

Feb 4, 2026

Study Type

INTERVENTIONAL

Conditions

Opioid-use Disorder

Summary

The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sham Stimulation and a medical device called Transcranial Direct Current Stimulation (tDCS) for people with buprenorphine and opioid-use disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Direct Current Stimulation (tDCS)

We will deliver 2-mA tDCS current intensity during a 30 minute stimulation period (including a 30-second ramp-up and 30-second ramp-down period) to the dorsolateral prefrontal cortex. Electrodes will be fixed on marked locations based on the 10-20 EEG system. Anodal stimulating electrode will be over the left DLPFC (F3) and cathodal electrode over the right DLPFC (F4).